Angle-closure Glaucoma Clinical Trial
Official title:
A Twelve-Week, Double Masked, Parallel Group, Primary-Therapy Pilot Study of the Safety and Efficacy of Travoprost 0.004% Compared to Pilocarpine 1% in Patients With Chronic Angle-Closure Glaucoma
The purpose of this study is to demonstrate that the Intraocular Pressure (IOP) lowering efficacy of Travoprost Ophthalmic Solution 0.004% is superior to that of Pilocarpine 1% in patients with chronic angle-closure glaucoma (CACG).
n/a
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT05163093 -
Research on the Diagnosis and Treatment of Angle Closure Glaucoma With Abnormal Lens Zonular
|
||
Recruiting |
NCT05563623 -
The Beijing Angle Closure Progression Study
|